HOLX

Q: What is the price of Hologic (HOLX) today?

The current price of Hologic (HOLX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 74.49 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Hologic (HOLX) pay dividends?

Hologic (HOLX) did not pay dividends over the past year.

Q: Is Hologic (HOLX) a good investment?

Hologic (HOLX) is currently trading at $ 0.00 with a P/E ratio of 31.30%. This represents a 2,645% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Hologic Inc.

Price

$ -

return (12m)

0.00%

p/e

31.30

p/bv

3.25

DIVIDEND YIELD

0.00%

HOLX price

HOLX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment HOLX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals HOLX

review the fundamentals of Hologic shares

P/E

31.30

Sector: -3.97 Industry: -4.31

P/S (PSR)

4.13

Sector: 1.88 Industry: 0.63

P/BV

3.25

Sector: 2.15 Industry: 1.33

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

5.92%

Sector: -29.79% Industry: -19.07%

ROE

10.37%

Sector: -35.24% Industry: -14.51%

ROIC

12.11%

Sector: -417.02% Industry: -113.78%

NET MARGIN

13.18%

Sector: -31.19% Industry: -20.37%

GROSS MARGIN

51.47%

Sector: 43.22% Industry: 28.66%

OPERATING MARGIN

19.21%

Sector: -26.40% Industry: -11.84%

EV/EBITDA

15.86

Sector: -1.86 Industry: -0.70

EV/EBIT

21.89

Sector: -3.23 Industry: 1.04

PRICE-TO-ASSETS

1.85

Sector: 1.12 Industry: 0.75

BVPS

23.42

Sector: 3.46 Industry: 5.18

EPS

2.43

Sector: -1.05 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.57

Sector: 0.41 Industry: 0.26

LIABILITIES / ASSETS

0.43

Sector: 0.45 Industry: 0.44

CAGR REVENUE 5 YEARS

-5.56%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-20.53%

Sector: - Industry: -

FAIR VALUE OF Hologic ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HOLX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	57.46	9.73	16.93%	0.00%	$ 171.19 B	28.15%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	25.86	0.00	0.00%	0.00%	$ 92.17 B	17.29%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
IDXX	42.73	28.20	65.99%	0.00%	$ 45.27 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
INMD	9.67	1.33	13.73%	0.00%	$ 907.20 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

HOLX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Hologic

Hologic Inc.

Average Investor10 user rating

4.0 (1 people)

United States

41 years

Founded: 1985

1990

Time since IPO - 36 years

6.478

Employees

Hologic Inc. (United States) is listed on the Nasdaq and has a market capitalization of $17.03 Billions, with shareholders equity totaling $5.25 Billions.

The company employs approximately 6.478 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Hologic Inc. reported $4.13 Billions in revenue, generating net income of $543.90 Millions.

Key financial metrics include a P/E ratio of 31.30, a price-to-book (P/B) ratio of 3.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HOLX.

Market cap

$ 17.03 Billions

Net worth

$ 5.25 Billions

$ 5,245,100,000.00

Assets

$ 9.18 Billions

$ 9,180,700,000.00

Total Shares Outstanding

224.00 Millions

224,000,000

Average Daily Trading Volume

$ 4.88 Millions

$ 4,877,819.52

Sector

Health

Industry

Medical Supplies and Equipment

HOLX

HOLX revenue and profits

Financial Results HOLX

DRAG THE FRAME TO SEE MORE DATA

HOLX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.94 24,95% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 275.64 --16,07% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 41.82 --27,51% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 215.23 --17,31% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

LLY - Eli Lilly

$ 883.96 1,49% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 145.42 32,22% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25

GSK - GlaxoSmithKline

$ 54.44 51,23% (12M)

P/E

15.37

3.00%

ROE

35.71%

P/BV

5.49